Alappattu26 | 18 | 8 | −10.0 | NR |
Barker et al.27 | 19.6 | 18 | −1.6 | 3 wk |
Baudic et al.28 | 14.6 | 21.5 | +6.9 | 1 yr |
Bostick et al.29 | 22.2 | 17.8 | −4.4 | 6 mo |
Chmielewski et al.31 | 3.7 | 2.5 | −1.2 | 9 wk |
Chmielewski et al.32 | 11.2 | 4 | −7.2 | 12 wk |
Clarke et al.33 | 19.5 | 13.0 | −6.5 | 2 h after drug administration |
Eyer et al.36 | NR | NR | −11.8 | 12 mo |
Forsythe et al.38 | 9.8 | 9.8 | 0.0 | 2 yr |
Hirakawa et al.40 | 13 | 9.3 | −3.7 | 3 wk |
Høvik et al.5 | 18.2 | 7.6† | −10.6† | |
Khan et al.6 | 11.69 | 10.84 | −0.59 | 48 h |
Lee et al.45 | 28.1 | 12.7 | −15.4 | 12 mo |
Lluch et al.46 | 22.6 | 6 | −16.6 | 5 mo |
Louw et al.47 | 23 | 13 | −10 | 1 d |
Martorella et al.49 | 1.04 | 1.19 | +0.15 | 7 d |
Miyazaki et al.50 | 24.2 | 7.1 | −14.1 | 3 mo |
Monticone et al.51 | 24.8 | 12.6 | −12.2 | 1 yr |
Ostelo et al.52 | 16.9 | NR | −7.3 | 1 yr |
Riddle et al.56 | 29.7 | 10.1 | −19.6 | 2 mo |
Tetsunaga et al.58 | 34.4 | 28 | −5.4 | 6 mo |
Tetsunaga et al.59 | 33.7 | 28.9 | −4.8 | 6 mo |
Tichonova et al.61 | 5.2 | 3.8 | −1.4 | Unclear (“after rehabilitation complete”) |
Vranceanu et al.65 | 14.8 | 3.8 | −11.0 | 4–6 wk |
Wade et al.66 | 14 | 7.32 | −6.68 | 6 mo |
Wideman et al.69 | 25.4 | 17.45 | −7.95 | NR |